| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5251532 | B | Inhibition of G9a (unknown origin) | Homo sapiens | 7 | single protein format | Scientific Literature | ||
| 2. | ALA5251533 | B | Inhibition of GLP (unknown origin) | Homo sapiens | 5 | single protein format | Scientific Literature | ||
| 3. | ALA5251534 | B | Inhibition of N-terminal GST-tagged human recombinant G9a (785 to 1210 residues) expressed in baculovirus infected Sf9 cells incubated for 1 hr by AlphaLISA analysis | Homo sapiens | 57 | cell-based format | Scientific Literature | ||
| 4. | ALA5251539 | F | Antiproliferative activity against human MOLT-4 cells assessed as inhibition of cell growth with replenishment of medium with compound on day 4 and 7 and measured after 12 days by ATPlite assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 5. | ALA5251541 | F | Downregulation of H3K9 dimethylation in human MOLT-4 cells at 1 uM by Western blot analysis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 6. | ALA5251542 | A | Cmax in ICR mouse at 25 mg/kg, ip | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 7. | ALA5251543 | A | AUC (0 to infinity) in ICR mouse at 25 mg/kg, ip | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 8. | ALA5251544 | A | Tmax in ICR mouse at 25 mg/kg, ip | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 9. | ALA5251545 | A | Half life in ICR mouse at 25 mg/kg, ip | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 10. | ALA5251546 | F | Antitumor activity against DEN-induced human HCC tumor in C57BL/6 mouse at 20 to 50 mg/kg, ip measured after 48 weeks | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA5251547 | T | Toxicity in C57BL/6 mouse assessed as body weight loss at 20 to 50 mg/kg, ip measured after 48 weeks | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA5251548 | F | Invivo inhibition of G9a in C57BL/6 mouse liver assessed as reduction in H3K9me2 level at 20 to 50 mg/kg, ip measured after 5 days by Westernblot analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA5251549 | A | Drug concentration in C57BL/6 mouse liver at 20 mg/kg, ip measured after 4 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA5251550 | A | Drug concentration in C57BL/6 mouse liver at 50 mg/kg, ip measured after 4 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA5251551 | A | Drug concentration in C57BL/6 mouse plasma at 20 mg/kg, ip measured after 4 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA5251552 | A | Drug concentration in C57BL/6 mouse plasma at 50 mg/kg, ip measured after 4 hrs | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA5251553 | F | Invivo inhibition of G9a in C57BL/6 mouse liver assessed as H3 histone methylation at 20 to 50 mg/kg, ip measured after 5 days by Westernblot analysis | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!